Summary of KDIGO 2024: Latest Updates on the Efficacy and Safety of Budesonide in Treating IgA Nephropathy
CPE point : 1 per event
This is an in-service training for the CUHK Medical Centre staff
Learning objectives:
Upon completion of the activity, participants will learn:
Objective 1: Update on Clinical Information of IgA Nephropathy
Objective 2: Understanding the Mechanism of Targeted Therapy Based on 4-Hit Pathogenesis
Objective 3: Practical Use of Nefecon Therapy
Objective 4: Application of KDIGO Guidelines in Clinical Practice
Date:
2025-04-07
Time:
1:00pm to 2:00pm
Venue:
L3 Pharmacy Library, CUHKMC
Organising Institute:
CUHK Medical Centre
Speaker:
Pinky Yuen Ping Hon, - Regional Senior Medical Affairs Manager at Everest Medicines
Related CPE Activities: